Friday, January 27, 2017 10:33:59 AM
Apparently you were mistaken:
https://www.sec.gov/litigation/complaints/2017/comp-pr2017-33.pdf
"On March 24,2016, Manzo issued a second press release, also drafted by Barton, restating the same misleading information contained in the February 16 press release.
89. At the same time that Manzo Pharmaceuticals issued the above misleading press releases, Barton, Goode and Peachtree converted their Manzo Pharmaceuticals debt into unregistered Manzo Pharmaceuticals stock and sold them to the public. All told, between June2014 and March 2016, Barton and Goode generated over $493,000 by selling 981 million shares of Manzo Pharmaceuticals stock"
https://www.sec.gov/litigation/complaints/2017/comp-pr2017-33.pdf
"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."
Upton Sinclair
"Nobody ever went broke underestimating the intelligence of the American public."
H. L. Mencken
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM